EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered Brain Tissue Volumes With Valproate Treatment for Schizophrenia

Thomas Cawood, Olivia K. Harrison, Meghan McIlwain, Robert R. Kydd, Bruce R. Russell

Journal of the Royal Society of New Zealand · 2026-04 · 56 (2)

DOI: 10.1002/snz2.70034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Royal Society of New Zealand, online erschienen am 23.03.2026. Verfasst von Thomas Cawood und 4 weiteren Autor:innen. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oakley Mental Health Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schizophrenia is a debilitating psychiatric condition that affects ≈0.5% of the global population. Some people with schizophrenia do not respond to first‐line antipsychotics and are prescribed clozapine; this is termed treatment‐resistant schizophrenia (TRS). When clozapine is ineffective for patients with TRS, and concomitant antipsychotics or mood stabilisers are required, this is termed ultra‐TRS (UTRS). Patients with UTRS are often prescribed augmentation therapy with mood stabilisers such as valproate to relieve residual symptoms. However, to date, the relationship between valproate and brain structure in people with schizophrenia has not been well described. Using magnetic resonance imaging, we found significant decreases in whole brain and white matter volumes in participants taking valproate compared to those taking clozapine without valproate. Further analyses revealed hypertrophy of grey matter in the cerebellum. This research indicates that using valproate augmentation in people with schizophrenia may alter white matter volumes and fractional anisotropy (FA) and grey matter density in the cerebellum and brainstem when compared to those receiving clozapine.

Förderung

  • Oakley Mental Health Research Foundation

Zitieren

APA

Cawood, T., Harrison, O. K., McIlwain, M., Kydd, R. R., & Russell, B. R. (2026). Altered Brain Tissue Volumes With Valproate Treatment for Schizophrenia. Journal of the Royal Society of New Zealand, 56(2). https://doi.org/10.1002/snz2.70034

Vancouver

Cawood T, Harrison OK, McIlwain M, Kydd RR, Russell BR. Altered Brain Tissue Volumes With Valproate Treatment for Schizophrenia. Journal of the Royal Society of New Zealand. 2026;56(2). doi:10.1002/snz2.70034

BibTeX
@article{Cawood2026,
  author = {Cawood, Thomas and Harrison, Olivia K. and McIlwain, Meghan and Kydd, Robert R. and Russell, Bruce R.},
  title = {Altered Brain Tissue Volumes With Valproate Treatment for Schizophrenia},
  journal = {Journal of the Royal Society of New Zealand},
  year = {2026},
  volume = {56},
  number = {2},
  doi = {10.1002/snz2.70034}
}
Kostenlos starten →